Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
Titel:
Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
Auteur:
Walraven, Maudy Homs, Marjolein Y. V. Veldt, Astrid A. M. van der Dekker, Henk Koldenhof, Jose Honeywell, Richard Barendrecht, Arjan Sebastian, Silvie A. E. Parr, Naomi Koekman, Arnold C. Voest, Emile E. Roest, Mark Korporaal, Suzanne J. A. Verheul, Henk M. W.